• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人的多重用药

Polypharmacy among the Elderly.

作者信息

Hosseini Seyed Reza, Zabihi Ali, Jafarian Amiri Seyedeh Roghayeh, Bijani Ali

机构信息

Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

Nursing Care Research Center, Babol University of Medical Sciences, Babol, Iran.

出版信息

J Midlife Health. 2018 Apr-Jun;9(2):97-103. doi: 10.4103/jmh.JMH_87_17.

DOI:10.4103/jmh.JMH_87_17
PMID:29962809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6006800/
Abstract

INTRODUCTION

Older people are at risk for polypharmacy due to multiple chronic diseases. Considering the lack of information in this regard, the aim of this study was to investigate the state of polypharmacy among the elderly in the city of Amirkola in northern part of Iran.

MATERIALS AND METHODS

This descriptive/analytical cross-sectional study is a part of Amirkola Health and Aging Project that was conducted on 1616 individuals aged 60 years and over. The data about medications were gathered through interviews and observation of prescriptions and medications consumed by patients. The data were analyzed by SPSS software version 18, and ≤ 0.05 was regarded significant.

RESULTS

In this study, 1616 individuals including 883 men (54.6%) and 733 women (45.3%) were investigated. The average age of individuals was 69.37 ± 7.42. Among the investigated individuals, 526 including 368 men (41.7%) and 158 women (21.6%) consumed no medications. The prevalence of polypharmacy in this study was 23.1%, which was 32.7% in women and 15.2% in men (odds ratio = 1.51, 95% confidence interval: 1.10-1.93). The most prevalent group of medications used in both genders was cardiovascular drugs.

CONCLUSIONS

Regarding the considerable prevalence of polypharmacy among the elderly, especially in aged women, serious efforts are required to manage polypharmacy. Provision of educational programs for physicians, personnel of pharmacies, and the staff of health-care centers in order for appropriate and safe consumption of medications in aged people is absolutely necessary.

摘要

引言

由于多种慢性疾病,老年人面临多重用药的风险。鉴于这方面信息的缺乏,本研究旨在调查伊朗北部阿米拉科拉市老年人多重用药的状况。

材料与方法

这项描述性/分析性横断面研究是阿米拉科拉健康与老龄化项目的一部分,该项目对1616名60岁及以上的个体进行了研究。通过访谈以及观察患者的处方和所服用的药物来收集用药数据。数据使用SPSS 18软件进行分析,P≤0.05被视为具有统计学意义。

结果

本研究共调查了1616名个体,其中男性883人(54.6%),女性733人(45.3%)。个体的平均年龄为69.37±7.42岁。在被调查个体中,526人(包括368名男性,占41.7%;158名女性,占21.6%)未服用任何药物。本研究中多重用药的患病率为23.1%,其中女性为32.7%,男性为15.2%(优势比=1.51,95%置信区间:1.10 - 1.93)。男女使用最普遍的药物类别均为心血管药物。

结论

鉴于老年人中多重用药的患病率相当高,尤其是老年女性,需要做出认真努力来管理多重用药问题。为医生、药剂师和医疗保健中心工作人员提供教育项目,以确保老年人合理、安全用药是绝对必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5370/6006800/65c6a0782292/JMH-9-97-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5370/6006800/4cae1efb3099/JMH-9-97-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5370/6006800/65c6a0782292/JMH-9-97-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5370/6006800/4cae1efb3099/JMH-9-97-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5370/6006800/65c6a0782292/JMH-9-97-g002.jpg

相似文献

1
Polypharmacy among the Elderly.老年人的多重用药
J Midlife Health. 2018 Apr-Jun;9(2):97-103. doi: 10.4103/jmh.JMH_87_17.
2
[Prevalence of Outpatient Use of Medicines by the Elderly Population in Portugal: A Cross-Sectional Study].[葡萄牙老年人群门诊用药患病率:一项横断面研究]
Acta Med Port. 2023 Dec 4;36(12):792-801. doi: 10.20344/amp.19254. Epub 2023 Jul 7.
3
Drug interactions in elderly (Amirkola Health and Ageing Project).老年人中的药物相互作用(阿米尔科拉健康与老龄化项目)
Caspian J Intern Med. 2022 Fall;13(4):786-794. doi: 10.22088/cjim.13.4.786.
4
Are older women likely to use medicines than older men? (Results from AHAP study).老年女性比老年男性更有可能使用药物吗?(AHAP研究结果)
Caspian J Intern Med. 2014 Spring;5(2):77-81.
5
Predictors of polypharmacy among elderly Thais with depressive and anxiety disorders: findings from the DAS study.老年泰国民众中同时患有抑郁和焦虑障碍者出现多重用药的预测因素:DAS 研究结果。
BMC Geriatr. 2018 Dec 12;18(1):309. doi: 10.1186/s12877-018-1001-2.
6
Frequency of Polypharmacy in Advanced Cancer Patients Consulted with the Palliative Service of Imam Khomeini Hospital (Tehran), Iran, 2017.2017年伊朗德黑兰伊玛目霍梅尼医院姑息治疗科会诊的晚期癌症患者多重用药频率
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):131-134. doi: 10.31557/APJCP.2019.20.1.131.
7
Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.巴西一家公立医院中机构养老老年患者的潜在药物相互作用和多重用药情况。
J Psychiatr Ment Health Nurs. 2018 Feb;25(1):3-13. doi: 10.1111/jpm.12431. Epub 2017 Oct 20.
8
Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy.意大利艾米利亚-罗马涅地区门诊老年患者多药治疗的流行率和风险:一项回顾性队列研究。
Drugs Aging. 2010 Dec 1;27(12):1019-28. doi: 10.2165/11584990-000000000-00000.
9
Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.60岁及以上患者的多重用药(多药合用)与慢性肾脏病:药物流行病学视角
Ther Adv Cardiovasc Dis. 2016 Aug;10(4):242-50. doi: 10.1177/1753944716634579. Epub 2016 Feb 25.
10
Any versus long-term prescribing of high risk medications in older people using 2012 Beers Criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12.依据2012年《比尔斯标准》对老年人使用高风险药物进行的短期与长期处方对比:来自2003/4年、2007/8年和2011/12年初级保健记录三个横断面样本的结果
BMC Geriatr. 2015 Nov 5;15:146. doi: 10.1186/s12877-015-0143-8.

引用本文的文献

1
Obesity Solutions for Patients over 65 Years of Age: Surgeon Perspectives on Anti-obesity Medications and Metabolic Bariatric Surgery - International Survey Study.65岁以上患者的肥胖解决方案:外科医生对减肥药物和代谢性减肥手术的看法——国际调查研究
Obes Surg. 2025 Jul 17. doi: 10.1007/s11695-025-08026-w.
2
The Prevalence of Polypharmacy and the Contribution of Age, Period, and Cohort Effects in Sweden From 2006 to 2020.2006年至2020年瑞典多重用药的患病率以及年龄、时期和队列效应的影响
Health Sci Rep. 2025 May 19;8(5):e70778. doi: 10.1002/hsr2.70778. eCollection 2025 May.
3
The Relation Between Polypharmacy, Potentially Inappropriate Medications, Organ Function, and Quality of Life in Elderly Patients with Type 2 Diabetes.

本文引用的文献

1
MEDICATION ADHERENCE IN ELDERLY WITH POLYPHARMACY LIVING AT HOME: A SYSTEMATIC REVIEW OF EXISTING STUDIES.居家服用多种药物的老年人的用药依从性:现有研究的系统评价
Mater Sociomed. 2016 Apr;28(2):129-32. doi: 10.5455/msm.2016.28.129-132. Epub 2016 Mar 25.
2
Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988-2010.美国65岁及以上成年人的多重用药情况:1988 - 2010年
J Gerontol A Biol Sci Med Sci. 2015 Aug;70(8):989-95. doi: 10.1093/gerona/glv013. Epub 2015 Mar 1.
3
Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study.
老年2型糖尿病患者多重用药、潜在不适当用药、器官功能与生活质量之间的关系
Hosp Pharm. 2025 May 11:00185787251337592. doi: 10.1177/00185787251337592.
4
Dual effects of and on hyperglycemia and infection in .[具体物质]和[具体物质]对[具体病症]中高血糖和感染的双重影响。
Narra J. 2025 Apr;5(1):e1972. doi: 10.52225/narra.v5i1.1972. Epub 2024 Feb 12.
5
Polypharmacy, drug-drug interactions, and potentially inappropriate medications among older adults: a cross-sectional study in Northeast Ethiopia.埃塞俄比亚东北部老年人的多重用药、药物相互作用及潜在不适当用药:一项横断面研究
Front Public Health. 2025 Apr 17;13:1525079. doi: 10.3389/fpubh.2025.1525079. eCollection 2025.
6
Medication use Pattern among the Elderly in Iran: A Review Article.伊朗老年人的用药模式:一篇综述文章。
Int J Prev Med. 2024 Oct 18;15:51. doi: 10.4103/ijpvm.ijpvm_142_23. eCollection 2024.
7
Medications Associated with Geriatric Syndromes and Prescribing Patterns: The Impact of Excessive Polypharmacy in Older Adult Patients.与老年综合征及处方模式相关的药物:老年患者多重用药过量的影响
Ther Clin Risk Manag. 2024 Oct 29;20:741-748. doi: 10.2147/TCRM.S493095. eCollection 2024.
8
Prevalence, Characteristics and Determinants of Polypharmacy Among Elderly Patients Attending Primary Healthcare Centres in Bahrain: A cross-sectional study.巴林初级医疗保健中心老年患者多重用药的患病率、特征及决定因素:一项横断面研究。
Sultan Qaboos Univ Med J. 2024 Feb;24(1):63-69. doi: 10.18295/squmj.9.2023.052. Epub 2024 Feb 28.
9
A Real-World Data Derived Pharmacovigilance Assessment on Drug-Induced Nephropathy: Implication on Gaps in Patient Care.基于真实世界数据的药物性肾病药物警戒评估:对患者护理差距的启示
Healthcare (Basel). 2023 Dec 31;12(1):95. doi: 10.3390/healthcare12010095.
10
Effect of using a mobile drug management application on medication adherence and hospital readmission among elderly patients with polypharmacy: a randomized controlled trial.移动药物管理应用对老年多病患者药物依从性和住院再入院的影响:一项随机对照试验。
BMC Health Serv Res. 2023 Nov 2;23(1):1192. doi: 10.1186/s12913-023-10177-4.
联合用药、潜在不适当用药及抗胆碱能负担对临床结局的影响:一项回顾性队列研究
CMAJ. 2015 Mar 3;187(4):E130-E137. doi: 10.1503/cmaj.141219. Epub 2015 Feb 2.
4
Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.社区居住老年人多重用药相关的健康结局:一项系统综述
J Am Geriatr Soc. 2014 Dec;62(12):2261-72. doi: 10.1111/jgs.13153.
5
Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005–2013.新西兰老年人9年期间(2005 - 2013年)多重用药和超多重用药的时间趋势
Gerontology. 2015;61(3):195-202. doi: 10.1159/000368191.
6
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI.老年人的多重疾病与多重用药:来自REPOSI的经验教训。
Intern Emerg Med. 2014 Oct;9(7):723-34. doi: 10.1007/s11739-014-1124-1. Epub 2014 Aug 28.
7
Prevalence and predictors of polypharmacy among Korean elderly.韩国老年人多重用药的患病率及预测因素
PLoS One. 2014 Jun 10;9(6):e98043. doi: 10.1371/journal.pone.0098043. eCollection 2014.
8
[Physicians need more pharmaceutical knowledge].医生需要更多的药学知识。
Lakartidningen. 2014;111(20):853.
9
[Polypharmacy issues in older adults].[老年人的多重用药问题]
Hu Li Za Zhi. 2014 Jun;61(3):97-104. doi: 10.6224/JN.61.3.97.
10
[Good prescribing practice in the elderly].[老年人的合理用药规范]
Ther Umsch. 2014 Jun;71(6):366-73. doi: 10.1024/0040-5930/a000524.